Lateral Canthal Lines
26
0
0
26
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Published Results
11 trials with published results (42%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 26 trials
100.0%
+13.5% vs benchmark
27%
7 trials in Phase 3/4
42%
11 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (26)
Princess® RICH for the Correction of Fine Lines
MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)
MT10109L in the Treatment of Lateral Canthal Lines
MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
Treatment of Moderate to Severe Lateral Canthal Lines
Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)
ET-01 in Subjects With Lateral Canthal Lines, LCL-208
ET-01 in Subjects With Lateral Canthal Lines
ET-01 in Subjects With Lateral Canthal Lines, LCL-207
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines
Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)
Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea
BOTOX® in the Treatment of Crow's Feet Lines in China
Dose Finding Study In Subjects With Crow's Feet
A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines